澳股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药生物股

660.947

-2.167-0.33%

涨家数：16

跌家数：10

平家数：19

市盈率：- -

高：664.779

开：660.784

低：654.741

收：663.114

成交量：3,942.76万

成交额：1.19亿

市值：986.34亿

流通市值：956.21亿

数据加载中...

总览新闻资讯

Mesoblast宣布James M. O’Brien被任命为首席财务官

新闻稿：詹姆斯·M·奥布莱恩被任命为美莎比信托首席财务官

BUZZ-奥布莱恩出任美国分部财务总监，Mesoblast 的澳大利亚股票攀升

澳大利亚收购委员会临时命令限制Cosette在未经事先同意的情况下采取任何终止Sid的措施

澳大利亚收购委员会 - 在特定情况下，委员会认为维持现状所需的临时命令是必要的

澳大利亚收购委员会 - 临时命令修订MAYNE PHARMA GROUP LTD与Cosette Pharma之间的方案实施契约结束日期定义

Mayne Pharma Group Ltd - 外国投资审查委员会将Firb批准的法定截止日期延长至11月17日

PROTEOMICS INTERNATIONAL LAB获得220万美元研发税收激励

Vaxxas 任命疫苗行业资深人士加入董事会，推动无针疫苗贴片迈向市场

Mayne Pharma - ASIC正式批准公司将2025年股东大会的召开时间从11月28日或之前延长至1月30日或之前

澳大利亚收购委员会 - Mayne寻求最终命令，包括Cosette同意将 FIRB 的决定法定截止日期延长至12月1日

澳大利亚收购委员会 - Mayne寻求临时命令，包括Cosette向委员会确认将与Firb会面

Mesoblast将于下月与FDA会谈讨论Rexlemestrocel-L和阿片类药物戒断

Mesoblast将于下月与FDA会面讨论Rexlemestrocel-L和药物戒断

Bioxyne Ltd - 与Curaleaf International签署澳大利亚独家进口、制造和供应协议

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK7508/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"医药生物股","latestPrice":660.94653,"timestamp":1763355599949,"preClose":663.1139,"halted":0,"volume":39427589,"delay":0,"changeRate":-0.003268,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-2.167358,"latestTime":"11-17 16:00:00 AEDT","open":660.78406,"high":664.77924,"low":654.7406,"amount":119314240,"amplitude":0.015139,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1763420400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763334000000,1763355600000]],"turnoverRate":0.001518,"increases":16,"decrements":13,"flats":14,"marketCap":98633810632.5,"floatMarketCap":95620565735.125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":664.77924,"amplitude":0.015139,"preClose":663.1139,"low":654.7406,"latestPrice":660.94653,"volume":39427589,"delay":0,"open":660.78406,"prevYearClose":936.801,"prevWeekClose":663.114,"prevMonthClose":662.953,"prevQuarterClose":712.826,"fiveDayClose":654.522,"twentyDayClose":782.253,"sixtyDayClose":774.804,"secType":"PLATE","market":"AU","turnoverRate":0.001518,"marketCap":98633810632.5,"floatMarketCap":95620565735.125,"timestamp":1763355599949,"nameCN":"医药生物股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":16,"down":10,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182398223","title":"Mesoblast宣布James M. O’Brien被任命为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1182398223","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182398223?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:14","pubTimestamp":1763367269,"startTime":"0","endTime":"0","summary":"11月17日 - Mesoblast Ltd：James M. O’Brien被任命为Mesoblast的首席财务官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7501","BK7508","BK7067"],"gpt_icon":0},{"id":"1195991725","title":"新闻稿：詹姆斯·M·奥布莱恩被任命为美莎比信托首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1195991725","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195991725?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 14:56","pubTimestamp":1763362561,"startTime":"0","endTime":"0","summary":"纽约，2025年11月17日-- 美莎比信托，全球领先的用于治疗炎症性疾病的同种异体细胞药物公司，今天宣布，在公司向一个完全整合的商业组织转型之际，任命詹姆斯·M·奥布莱恩为其美国首席财务官。詹姆斯在财务管理和规划的各个方面拥有丰富经验，职业生涯的大部分时间都在生命科学、生物技术和制药行业的跨国公私公司中度过。本发布已获首席执行官授权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","BK4139","BK4150","BK4022","MSB.AU","BK4575","BK4006","MSB","BMS","BK7067","BK7501","BK7508","MESO","R","MSC","BK4232"],"gpt_icon":0},{"id":"2584924916","title":"BUZZ-奥布莱恩出任美国分部财务总监，Mesoblast 的澳大利亚股票攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2584924916","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584924916?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 09:11","pubTimestamp":1763341883,"startTime":"0","endTime":"0","summary":"11月17日 - ** 在澳大利亚证券交易所上市的炎症性疾病药物生产商Mesoblast MSB.AX的股价上涨3.6%，达到2.3澳元，结束了连续两个交易日的下跌。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nL4T3WT01H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","CGTX","BK7501","MSB.AU","BK7067","BK4007"],"gpt_icon":0},{"id":"1134813682","title":"澳大利亚收购委员会临时命令限制Cosette在未经事先同意的情况下采取任何终止Sid的措施","url":"https://stock-news.laohu8.com/highlight/detail?id=1134813682","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134813682?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 12:51","pubTimestamp":1763095870,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会临时命令限制Cosette在未经事先同意的情况下采取任何终止Sid的措施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"1167970201","title":"澳大利亚收购委员会 - 在特定情况下，委员会认为维持现状所需的临时命令是必要的","url":"https://stock-news.laohu8.com/highlight/detail?id=1167970201","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167970201?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 12:50","pubTimestamp":1763095823,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - 在特定情况下，委员会认为维持现状所需的临时命令是必要的","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"1157529952","title":"澳大利亚收购委员会 - 临时命令修订MAYNE PHARMA GROUP LTD与Cosette Pharma之间的方案实施契约结束日期定义","url":"https://stock-news.laohu8.com/highlight/detail?id=1157529952","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157529952?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 12:50","pubTimestamp":1763095813,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - 临时命令修订MAYNE PHARMA GROUP LTD与Cosette Pharma之间的方案实施契约结束日期定义","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1175509821","title":"Mayne Pharma Group Ltd - 外国投资审查委员会将Firb批准的法定截止日期延长至11月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=1175509821","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175509821?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 11:46","pubTimestamp":1763005569,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd - 外国投资审查委员会将Firb批准的法定截止日期延长至11月17日","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"1109160475","title":"PROTEOMICS INTERNATIONAL LAB获得220万美元研发税收激励","url":"https://stock-news.laohu8.com/highlight/detail?id=1109160475","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109160475?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 06:05","pubTimestamp":1762898708,"startTime":"0","endTime":"0","summary":"PROTEOMICS INTERNATIONAL LAB获得220万美元研发税收激励","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"1131670486","title":"Vaxxas 任命疫苗行业资深人士加入董事会，推动无针疫苗贴片迈向市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1131670486","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131670486?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 21:03","pubTimestamp":1762779790,"startTime":"0","endTime":"0","summary":"Vaxxas 任命疫苗行业资深人士加入董事会，以推动无针疫苗贴片向市场迈进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MVP.AU","BK7508"],"gpt_icon":0},{"id":"1199687473","title":"Mayne Pharma - ASIC正式批准公司将2025年股东大会的召开时间从11月28日或之前延长至1月30日或之前","url":"https://stock-news.laohu8.com/highlight/detail?id=1199687473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199687473?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 14:46","pubTimestamp":1762497972,"startTime":"0","endTime":"0","summary":"Mayne Pharma - ASIC正式批准公司将2025年股东大会的召开时间从11月28日或之前延长至1月30日或之前","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"1180672738","title":"澳大利亚收购委员会 - Mayne寻求最终命令，包括Cosette同意将 FIRB 的决定法定截止日期延长至12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=1180672738","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180672738?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 15:35","pubTimestamp":1762414512,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - Mayne寻求最终命令，包括Cosette同意将 FIRB 的决定法定截止日期延长至12月1日","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1130202281","title":"澳大利亚收购委员会 - Mayne寻求临时命令，包括Cosette向委员会确认将与Firb会面","url":"https://stock-news.laohu8.com/highlight/detail?id=1130202281","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130202281?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 15:34","pubTimestamp":1762414452,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - Mayne寻求临时命令，包括Cosette向委员会确认将与Firb会面","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1116191251","title":"Mesoblast将于下月与FDA会谈讨论Rexlemestrocel-L和阿片类药物戒断","url":"https://stock-news.laohu8.com/highlight/detail?id=1116191251","media":"投资观察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116191251?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 09:45","pubTimestamp":1762307124,"startTime":"0","endTime":"0","summary":"11月5日（路透社） - Mesoblast Ltd：*MESOBLAST将于下月与FDA会面，讨论Rexlemestrocel-L和阿片类药物戒断* 进一步公司报道：MSB.AX","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7067","MSB.AU"],"gpt_icon":0},{"id":"1199521939","title":"Mesoblast将于下月与FDA会面讨论Rexlemestrocel-L和药物戒断","url":"https://stock-news.laohu8.com/highlight/detail?id=1199521939","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199521939?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 06:59","pubTimestamp":1762297168,"startTime":"0","endTime":"0","summary":"Mesoblast将于下月与FDA会面，讨论Rexlemestrocel-L和药物戒断的相关事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","MESO","MSB.AU","BK4139","BK7508","BK7501"],"gpt_icon":0},{"id":"1136919449","title":"Bioxyne Ltd - 与Curaleaf International签署澳大利亚独家进口、制造和供应协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1136919449","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136919449?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 05:30","pubTimestamp":1762119009,"startTime":"0","endTime":"0","summary":"Bioxyne Ltd - 与Curaleaf International签署澳大利亚独家进口、制造和供应协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7111","BXN.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}